NV

NYBC Ventures

North America, Massachusetts, United States, Boston

Description

NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies.

Investor Profile

NYBC Ventures has made 13 investments, with 2 in the past 12 months and 46% as lead.

Stage Focus

  • Seed (46%)
  • Series Unknown (31%)
  • Series C (8%)
  • Series A (8%)
  • Series B (8%)

Country Focus

  • United States (92%)
  • The Netherlands (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Bioinformatics
  • Test And Measurement
  • Pharmaceutical
  • Life Science
  • Emergency Medicine
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NYBC Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Qatar Investment Authority
Asia, Ad Dawhah, Qatar, Doha
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
CH
North America, New York, United States, New York
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does NYBC Ventures often collaborate with?

JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
PR
North America, Massachusetts, United States, Boston
Shared Deals: 1
JP
North America, United States
Shared Deals: 1
GC
North America, Massachusetts, United States, Boston
Shared Deals: 1
MB
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by NYBC Ventures?

AvenCell

Watertown, Massachusetts, United States

Based on our deep science and focused on patients in need.

Health Care
Series BOct 22, 2024
Amount Raised: $112,000,000
Vitestro

Utrecht, Utrecht, The Netherlands

Vitestro transform patient care with autonomous blood drawing technology.

Health CareMedical Device
Series AApr 30, 2024
Amount Raised: $21,332,150
Functional Fluidics

Detroit, Michigan, United States

Functional Fluidics specializes in the standardization of clinical blood function assays to assess individual patient response.

Health Care
Series UnknownDec 7, 2023
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
Series UnknownNov 14, 2023
Amount Raised: $15,000,000
Aronora

Portland, Oregon, United States

Aronora A biotech company focusing on the development of safer biologic drugs.

Biotechnology
SeedOct 12, 2023
Star Therapeutics

South San Francisco, California, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Health CareMedicalTherapeutics
Series CSep 5, 2023
Amount Raised: $90,000,000
Veralox Therapeutics

Frederick, Maryland, United States

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownJun 20, 2023
Amount Raised: $24,000,000
Kalocyte

Baltimore, Maryland, United States

Kalocyte provides red blood cell substitutes used for trauma care related services.

BiotechnologyEmergency MedicineHealth Care
SeedMay 11, 2023
HealthQuest Capital

Redwood City, California, United States

HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry

Series UnknownMay 11, 2023
STRM.BIO

Cambridge, Massachusetts, United States

STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.

Biotechnology
SeedMay 11, 2023